November 23, 2016 09:28 AM ESTUpdated 09:50 AM
News Briefing

Pfiz­er blue­prints $200M R&D cam­pus; Gala­pa­gos bags $50M mile­stone from Gilead

Shehla Shakoor

Managing Director

Pfiz­er is build­ing a new R&D cam­pus in St. Louis for more than 600 staffers cur­rent­ly de­ployed at two near­by lo­ca­tions. This new con­sol­i­da­tion project …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times